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European Journal of Cardio-thoracic Surgery 36 (2009) 609—6101 SYNTAX supplemental data. Accessible @ http://content.nejm.org/cgi/
data/NEJMoa0804626/DC1/1.In this issue of the European Journal of Cardiothoracic
Surgery, a meta-analysis to compare coronary artery bypass
grafting (CABG) versus drug-eluting stents (DESs) in multi-
vessel coronary disease is presented. The authors claim that
the original observational studies that were included in their
meta-analysis would reflect ‘the real world clinical practice’
and should therefore be used to support the results of
randomised trials and determine the standard of care [1].
Without going into the details, the authors pool the data of
nine different studies that show only one thing in common: a
substantial variation with regard to patient characteristics.
To give only an example, Table 1 (see Ref. [1]) summarises the
number and percentage of patients with double-vessel
disease, triple-vessel disease and left main stem stenosis
in each group. From this summary, it is obvious that there was
no similarity in the patients treated in any of the original
studies. While most patients in the CABG groups had triple-
vessel disease, more involvement of the left anterior
descending coronary artery (LAD), more chronic occlusions
and a higher prevalence of left main disease, most patients in
the DES groups had double-vessel disease alone, a substantial
number without involvement of the LAD.
It is important to note that the quoted retrospective
studies used for this (and other) meta-analysis used different
inclusion criteria and definitions with often substantial
variations. According to a study [2], the definition of
multi-vessel percutaneous coronary intervention (PCI) was
as follows: ‘PCI in two or more major epicardial coronary
arteries or one major artery and a branch originating from
another major epicardial artery supplying different myocar-
dial regions.’ By this definition, stenting of a small diagonal
branch as well as the distal circumflex artery could be defined
as ‘multi-vessel stenting’. This is clearly not the surgical
understanding of treating multi-vessel disease. For years,
Taggart has pointed out that in almost all studies comparing
CABG and PCI there was no equal distribution with regard to
the extent of disease [3,4]. Since the early days of PCI, it is
known, that in patients with double-vessel disease and
normal left ventricular function, there is no immediate
survival benefit for CABG over PCI. It is the patients with
triple-vessel disease involving the LAD who have the largest
benefit of CABG [5].1010-7940/$ — see front matter # 2009 European Association for Cardio-Thoracic
doi:10.1016/j.ejcts.2009.03.070The largest study so far on this subject by Hannan et al.
comprises 69.3% of the CABG (7437 out of 10 728) and 73.6%
of the stent patients (9963 out of 13 540) used for the meta-
analysis by Benedetto et al. [6]. The added value of pooling
these well-defined data with eight much smaller sources that
used different data sets and outcome measures remains
uncertain. All the authors of the original studies quoted in the
meta-analysis agree that the original population of their
retrospective analyses differed for the two groups for
severity of illness and many variables including diabetes,
age and other confounding factors. Thus, propensity analysis
and adjustments to account for differences in periprocedural
risk were applied in some but not all studies. Few studies used
proportional hazard Cox regression models or other less well-
accepted statistics to correct for the underlying risk. It is not
known how and if the extent of coronary artery disease was
always used as a confounding variable, but certainly it was
not used uniformly as an independent risk factor.
The SYNTAX score describes the coronary vasculature with
respect to the number and complexity of lesions. A high
SYNTAX score (or more complex disease) is a predictor for an
increased rate of re-intervention after primary PCI and stent
implantation [7] In contrast, CABG does not only treat the
culprit lesion but also deals with ‘future culprit lesions’
because the graft is usually placed to the mid or distal vessel
[4]. As a result, lesion complexity has less of an impact on the
1-year results after CABG for triple-vessel disease [8].1
The presented meta-analysis does not provide new
evidence that could guide clinical decision making for the
treatment of patients with multi-vessel disease. Therefore,
we should continue to refer to the best-available evidence
provided by the study of Hannan et al. who arrived at a clear-
cut conclusion: already after 18 months CABG is associated
with lower mortality rates and lower rates for death or
myocardial infarction and repeat re-vascularisation than
treatment with DESs [4]. Since we already know from the
ARTS trial that the gap between PCI and CABG tends to get
larger in favour of CABG over time, this statement will most
likely get stronger as time goes by.Surgery. Published by Elsevier B.V. All rights reserved.
Editorial / European Journal of Cardio-thoracic Surgery 36 (2009) 609—610610The other piece of meaningful information from ‘the real
world’ comes from the all-comers randomised SYNTAX trial
that concluded with the statement that CABG remains the
standard of care for patients with three-vessel or left main
coronary artery disease, since the use of CABG, as compared
to PCI with DES, resulted in lower rates of the combined end
point of major adverse cardiac events (MACE) at 1 year [9].
This is in line with the recently published ACCF/SCAI/STS/
AATS/AHA/ASNC 2009 appropriateness criteria for coronary
re-vascularisation for patients with advanced CAD and the
necessity for coronary re-vascularisation [10]. CABG was
rated as appropriate in all of the clinical scenarios
developed, whereas PCI was rated appropriate only in
patients with two-vessel CAD with involvement of the
proximal LAD and rated uncertain in patients with three-
vessel disease. For patients with left main stenosis and/or
left main stenosis andmulti-vessel CAD, CABG but not PCI was
rated appropriate and likely to improve patients’ health
outcomes or survival (see Fig. 1 in Ref. [10]).
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